SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Illumina, Inc. – ‘10-Q’ for 7/2/23 – ‘EX-32.2’

On:  Thursday, 8/10/23, at 4:38pm ET   ·   For:  7/2/23   ·   Accession #:  1110803-23-64   ·   File #:  1-35406

Previous ‘10-Q’:  ‘10-Q’ on 5/5/23 for 4/2/23   ·   Next:  ‘10-Q’ on 11/13/23 for 10/1/23   ·   Latest:  ‘10-Q’ on 5/3/24 for 3/31/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/10/23  Illumina, Inc.                    10-Q        7/02/23   73:8.1M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.81M 
 2: EX-10.1     Material Contract                                   HTML    104K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
12: R1          Cover Page                                          HTML     73K 
13: R2          Condensed Consolidated Balance Sheets               HTML    122K 
14: R3          Condensed Consolidated Statements of Operations     HTML    120K 
15: R4          Condensed Consolidated Statements of Comprehensive  HTML     40K 
                Income (Loss)                                                    
16: R5          Condensed Consolidated Statements of Stockholders?  HTML    120K 
                Equity                                                           
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    111K 
18: R7          Organization and Significant Accounting Policies    HTML     51K 
19: R8          Revenue                                             HTML     90K 
20: R9          Investments and Fair Value Measurements             HTML     94K 
21: R10         Debt                                                HTML     59K 
22: R11         Stockholders? Equity                                HTML     87K 
23: R12         Supplemental Balance Sheet Details                  HTML     90K 
24: R13         Legal Proceedings                                   HTML     33K 
25: R14         Income Taxes                                        HTML     29K 
26: R15         Segment Information                                 HTML     56K 
27: R16         Pay vs Performance Disclosure                       HTML     34K 
28: R17         Insider Trading Arrangements                        HTML     47K 
29: R18         Organization and Significant Accounting Policies    HTML     39K 
                (Policies)                                                       
30: R19         Organization and Significant Accounting Policies    HTML     40K 
                (Tables)                                                         
31: R20         Revenue (Tables)                                    HTML     84K 
32: R21         Investments and Fair Value Measurements (Tables)    HTML     90K 
33: R22         Debt (Tables)                                       HTML     44K 
34: R23         Stockholders? Equity (Tables)                       HTML    106K 
35: R24         Supplemental Balance Sheet Details (Tables)         HTML     90K 
36: R25         Segment Information (Tables)                        HTML     51K 
37: R26         Organization and Significant Accounting Policies -  HTML     37K 
                Summary of Calculation of Weighted Average Shares                
                used to Calculate Basic and Diluted Earnings Per                 
                Share (Details)                                                  
38: R27         Revenue - Disaggregation of Revenue (Details)       HTML     62K 
39: R28         Revenue - Performance Obligation (Details)          HTML     38K 
40: R29         Revenue - Narrative (Details)                       HTML     31K 
41: R30         Investments and Fair Value Measurements -           HTML    109K 
                Narrative (Details)                                              
42: R31         Investments and Fair Value Measurements - Schedule  HTML     29K 
                of Marketable Equity Securities (Details)                        
43: R32         Investments and Fair Value Measurements - Fair      HTML     57K 
                Value Hierarchy of Assets and Liabilities                        
                (Details)                                                        
44: R33         Investments and Fair Value Measurements - Changes   HTML     28K 
                in Estimated Fair Value of Acquisition Related                   
                Contingent Consideration Liabilities (Details)                   
45: R34         Debt - Summary of Term Debt Obligations (Details)   HTML     55K 
46: R35         Debt - Narrative (Details)                          HTML    118K 
47: R36         Debt - Summary of Convertible Debt Obligations      HTML     44K 
                (Details)                                                        
48: R37         Stockholders? Equity - Narrative (Details)          HTML     48K 
49: R38         Stockholders? Equity - Summary of Restricted Stock  HTML     52K 
                Activity and Related Information (Details)                       
50: R39         Stockholders? Equity - Summary of Stock Option      HTML     51K 
                Activity Under all Stock Option Plans (Details)                  
51: R40         Stockholders? Equity - Narrative - Other Liability  HTML     45K 
                - Classified Awards (Details)                                    
52: R41         Stockholders? Equity - Other Liability -            HTML     36K 
                Classified Awards (Details)                                      
53: R42         Stockholders? Equity - Narrative - Employee Stock   HTML     38K 
                Purchase Plan (Details)                                          
54: R43         Stockholders? Equity- Summary of Assumptions Used   HTML     50K 
                to Estimate the Weighted Average Fair Value Per                  
                Share (Details)                                                  
55: R44         Stockholders? Equity - Narrative - Share            HTML     34K 
                Repurchases (Details)                                            
56: R45         Stockholders? Equity - Summary of Share-based       HTML     46K 
                Compensation Expense for all Stock Awards                        
                (Details)                                                        
57: R46         Supplemental Balance Sheet Details - Schedule of    HTML     29K 
                Accounts Receivable (Details)                                    
58: R47         Supplemental Balance Sheet Details - Summary of     HTML     34K 
                Inventory (Details)                                              
59: R48         Supplemental Balance Sheet Details - Summary of     HTML     39K 
                Accrued Liabilities (Details)                                    
60: R49         Supplemental Balance Sheet Details - Summary of     HTML     29K 
                Changes in Reserve for Product Warranties                        
                (Details)                                                        
61: R50         Supplemental Balance Sheet Details - Pre-Tax        HTML     36K 
                Restructuring Charge (Details)                                   
62: R51         Supplemental Balance Sheet Details - Pre-Tax        HTML     45K 
                Charges and Total Costs (Details)                                
63: R52         Supplemental Balance Sheet Details - Narrative -    HTML     29K 
                Warranties (Details)                                             
64: R53         Supplemental Balance Sheet Details - Narrative -    HTML     44K 
                Goodwill (Details)                                               
65: R54         Supplemental Balance Sheet Details - Narrative -    HTML     51K 
                Derivatives (Details)                                            
66: R55         Legal Proceedings (Details)                         HTML     33K 
67: R56         Income Taxes (Details)                              HTML     33K 
68: R57         Segment Information - Summary of Operating          HTML     43K 
                Performance and Assets by Segment (Details)                      
71: XML         IDEA XML File -- Filing Summary                      XML    130K 
69: XML         XBRL Instance -- ilmn-20230702_htm                   XML   1.74M 
70: EXCEL       IDEA Workbook of Financial Report Info              XLSX    129K 
 8: EX-101.CAL  XBRL Calculations -- ilmn-20230702_cal               XML    167K 
 9: EX-101.DEF  XBRL Definitions -- ilmn-20230702_def                XML    662K 
10: EX-101.LAB  XBRL Labels -- ilmn-20230702_lab                     XML   1.73M 
11: EX-101.PRE  XBRL Presentations -- ilmn-20230702_pre              XML   1.02M 
 7: EX-101.SCH  XBRL Schema -- ilmn-20230702                         XSD    148K 
72: JSON        XBRL Instance as JSON Data -- MetaLinks              518±   764K 
73: ZIP         XBRL Zipped Folder -- 0001110803-23-000064-xbrl      Zip    370K 


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 32.2
CERTIFICATION OF JOYDEEP GOSWAMI PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Illumina, Inc. (the “Company”) on Form 10-Q for the quarter ended July 2, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joydeep Goswami, Chief Financial Officer, Chief Strategy and Corporate Development Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 10, 2023
 By: 
/s/ JOYDEEP GOSWAMI
 Name: Joydeep Goswami
 Title: Chief Financial Officer, Chief Strategy and Corporate Development Officer

This certification accompanying the Report is not deemed filed with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such Section, and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before, on or after the date of the Report), irrespective of any general incorporation language contained in such filing.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/10/23None on these Dates
For Period end:7/2/23
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  Illumina, Inc.                    10-K       12/31/23  111:18M
 1/09/24  Illumina, Inc.                    8-K:2,9     1/09/24   11:227K
11/13/23  Illumina, Inc.                    10-Q       10/01/23   75:8.2M
11/09/23  Illumina, Inc.                    8-K:2,9    11/09/23   11:1.2M


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/05/23  Illumina, Inc.                    10-Q        4/02/23   67:7.1M
 2/17/23  Illumina, Inc.                    10-K        1/01/23  108:17M
 8/11/22  Illumina, Inc.                    10-Q        7/03/22   72:9M
 2/18/22  Illumina, Inc.                    10-K        1/02/22  108:15M
 8/18/21  Illumina, Inc.                    8-K:1,2,8,9 8/18/21   12:686K                                   Cravath Swaine & … 01/FA
Top
Filing Submission 0001110803-23-000064   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 7:28:45.1am ET